Sotera Health Company

NasdaqGS SHC

Sotera Health Company Price to Earnings Ratio (P/E) on January 14, 2025: 51.09

Sotera Health Company Price to Earnings Ratio (P/E) is 51.09 on January 14, 2025, a -38.87% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Sotera Health Company 52-week high Price to Earnings Ratio (P/E) is 119.38 on September 16, 2024, which is 133.68% above the current Price to Earnings Ratio (P/E).
Sotera Health Company 52-week low Price to Earnings Ratio (P/E) is 49.68 on November 21, 2024, which is -2.74% below the current Price to Earnings Ratio (P/E).
Sotera Health Company average Price to Earnings Ratio (P/E) for the last 52 weeks is 74.03.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

NasdaqGS: SHC

Sotera Health Company

CEO	Mr. Michael B. Petras Jr.
IPO Date	Nov. 20, 2020
Location	United States
Headquarters	9100 South Hills Boulevard
Employees	3,000
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.

Key trends

Past 5 years